Harpreet S. Dhaliwal - Sep 2, 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Chief Technical Ops Officer
Signature
Harpreet S. Dhaliwal, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol
PCVX
Transactions as of
Sep 2, 2025
Transactions value $
-$48,539
Form type
4
Date filed
9/4/2025, 04:12 PM
Previous filing
Apr 25, 2025
Next filing
Sep 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dhaliwal Harpreet S. Chief Technical Ops Officer C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Harpreet S. Dhaliwal, by /s/ Peter N. Efremenko, Attorney-In-Fact 2025-09-04 0001886794

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability -$9.18K -291 -0.8% $31.56 36.1K Sep 2, 2025 Direct F1, F2
transaction PCVX Common Stock Tax liability -$24.7K -783 -2.17% $31.56 35.3K Sep 2, 2025 Direct F1
transaction PCVX Common Stock Tax liability -$14.6K -464 -1.31% $31.56 34.9K Sep 2, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F2 Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.